Dr. Amos O. Abioye is an Associate Professor at the College of Pharmacy & Health Sciences at Belmont University. Before joining Belmont University, he worked as an Associate Professor of Pharmaceutical Sciences at Palm Beach Atlantic University from 2018 to 2022. He obtained his B.Pharm. from Obafemi Awolowo University, Nigeria, his Postgraduate Diploma for Overseas Pharmacists from Aston University, UK, and his M.S. and Ph.D. in Pharmaceutics and Pharmaceutical Technology from the University of Lagos, Nigeria. Dr. Abioye’s broad research focus includes the development of smart drug delivery and targeting systems with age-appropriate and flexible dosing, especially for poorly soluble drugs, personalized nanomedicines and taste masking of ‘bitter’ drugs. Dr. Abioye is a registered pharmacist with the General Pharmaceutical Council (GPhC) United Kingdom, and is a member of the Royal Pharmaceutical Society (RPharmS) and Great Britain Academy of Pharmaceutical Sciences (APSGB). He is also a member of the American Association of Pharmaceutical Scientists (AAPS), American Society for Microbiology (ASM) and American Association of Colleges of Pharmacy (AACP) in the United States.
Dr. Amos O. Abioye is an Associate Professor at the College of Pharmacy & Health Sciences at Belmont University. Before joining Belmont University, he worked as an Associate Professor of Pharmaceutical Sciences at Palm Beach Atlantic University from 2018 to 2022. He obtained his B.Pharm. from Obafemi Awolowo University, Nigeria, his Postgraduate Diploma for Overseas Pharmacists from Aston University, UK, and his M.S. and Ph.D. in Pharmaceutics and Pharmaceutical Technology from the University of Lagos, Nigeria. Dr. Abioye’s broad research focus includes the development of smart drug delivery and targeting systems with age-appropriate and flexible dosing, especially for poorly soluble drugs, personalized nanomedicines and taste masking of ‘bitter’ drugs. Dr. Abioye is a registered pharmacist with the General Pharmaceutical Council (GPhC) United Kingdom, and is a member of the Royal Pharmaceutical Society (RPharmS) and Great Britain Academy of Pharmaceutical Sciences (APSGB). He is also a member of the American Association of Pharmaceutical Scientists (AAPS), American Society for Microbiology (ASM) and American Association of Colleges of Pharmacy (AACP) in the United States.